secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tilray Brands, Inc. (TLRY)
CIK:        0001731348
Form:       8-K
Filed at:   2026-04-15T23:59:59+00:00
Accession:  0001140361-26-014692
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tilray acquires UK medical platform Lyphe; files $180M ATM for beverage expansion
--------------------------------------------------------------------------------

- Acquired Lyphe Group, a UK medical cannabis clinic/pharmacy; dispensed ~150K units, treated 16K+ patients; expected accretive in 2027.
- Filed ATM equity program of up to $180M to invest in global beverage platform; managed by Jefferies, TD Securities, Roth Capital.
- BrewDog (acquired six weeks ago) stabilizing; expects cash-flow positive in 2027; investing in brand and brewpub modernization.
- Plans to launch Hi*Ball Energy in UK in May; evaluating US medical cannabis rescheduling and CMS pilot program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1731348/000114036126014692/0001140361-26-014692-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1731348/000114036126014692/ny20066669x2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-014692

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer